Skip to main content
Top
Published in: Infection 6/2022

Open Access 06-05-2022 | Human Papillomavirus | Original Paper

Implementation of EACS vaccination recommendations among people living with HIV

Authors: Sven Breitschwerdt, Carolynne Schwarze-Zander, Ahmad Al Tayy, Julia Mutevelli, Jan-Christian Wasmuth, Jürgen K. Rockstroh, Christoph Boesecke

Published in: Infection | Issue 6/2022

Login to get access

Abstract

Objectives

With modern combination antiretroviral Treatment (cART) a normal life expectancy among people living with HIV (PLWH) has become reality if started early enough prior to the onset of more pronounced immunodeficiency. Therefore, prevention measures against other infectious diseases among this vulnerable group have gained increased attention. Indeed, the EACS guidelines recommend vaccinations against HAV, HBV, HPV, Influenza, Neisseria meningitidis, Streptococcus pneumoniae and VZV in HIV-infected adults.

Methods

All PLWH under cART attending our ID outpatient clinic between April to June 2018, were assessed during consultation for vaccination status regarding pneumococcus, Hepatitis A and B, influenza, varicella, meningococcus and HPV using a pre-defined questionnaire, vaccination certificates and medical records. In addition, the cohort database was screened for Hepatitis A and B serology and HIV surrogate markers.

Results

A total of 305 PLWH (82.3% male, 17.7% female) was included, median age was 48 years (IQR 47–51). Median CD4 + T cell count was 543 (IQR 304–770), and for 297 (97.4%) PLWH CD4 + T cell count was ≥ 200/ul. The viral load was undetectable (< 40 copies/ml) in 289 (94.8%) cases. Highest vaccination rates were observed for HAV (87.4%), Streptococcus pneumoniae (77.4%) and Influenza (76.5%). 64.3% PLWH got vaccinated against HBV, whereas VZV vaccination only played a minor role, in the context of the high rate of cleared infections (99.0%). Lowest vaccination rates were detected for HPV (0%) and Neisseria meningitidis (3.0%).

Conclusions

Our data suggest that vaccination rates among PLWH are higher compared to the general German population. Implementation of EACS guidelines into daily routine though is not fully executed and the need for improving vaccination rates has to be emphasized. Centrally organized vaccination registers as well as electronic medical records could be helpful tools to detect a lack of vaccination coverage and send digital vaccination reminders particularly among risk groups.
Literature
1.
go back to reference Hagemann C, et al. Specific varicella-related complications and their decrease in hospitalized children after the introduction of general varicella vaccination: results from a multicenter pediatric hospital surveillance study in Bavaria (Germany). Infect Dis Ther. 2019;8:597–611.CrossRefPubMedPubMedCentral Hagemann C, et al. Specific varicella-related complications and their decrease in hospitalized children after the introduction of general varicella vaccination: results from a multicenter pediatric hospital surveillance study in Bavaria (Germany). Infect Dis Ther. 2019;8:597–611.CrossRefPubMedPubMedCentral
2.
go back to reference Ryan J, et al. Establishing the health and economic impact of influenza vaccination within the European union 25 countries. Vaccine. 2006;24:6812–22.CrossRefPubMed Ryan J, et al. Establishing the health and economic impact of influenza vaccination within the European union 25 countries. Vaccine. 2006;24:6812–22.CrossRefPubMed
3.
go back to reference Chen C, et al. Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia. Vaccine. 2018;36:6307–13.CrossRefPubMed Chen C, et al. Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia. Vaccine. 2018;36:6307–13.CrossRefPubMed
4.
go back to reference Gil-Prieto R, et al. Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain. Vaccine. 2014;32:7043–6.CrossRefPubMed Gil-Prieto R, et al. Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain. Vaccine. 2014;32:7043–6.CrossRefPubMed
5.
go back to reference Robert-Koch-Institut, Online-Befragung von Klinikpersonal zur Influenza-Impfung (OKaPII-Studie), Epidemiologischen Bulletin 47/2016. 2016. Robert-Koch-Institut, Online-Befragung von Klinikpersonal zur Influenza-Impfung (OKaPII-Studie), Epidemiologischen Bulletin 47/2016. 2016.
7.
go back to reference Gößwald A, Lange M, Kamtsiuris P, Kurth B-M. DEGS: Studie zur Gesundheit Erwachsener in Deutschland. Bundesgesundheitsblatt. 2020;55:775–780. Gößwald A, Lange M, Kamtsiuris P, Kurth B-M. DEGS: Studie zur Gesundheit Erwachsener in Deutschland. Bundesgesundheitsblatt. 2020;55:775–780.
8.
go back to reference Puoti M, et al. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev. 2002;4:27–35.PubMed Puoti M, et al. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev. 2002;4:27–35.PubMed
9.
go back to reference Bödeker B, et al. Influenza, tetanus, and pertussis vaccination coverage among adults in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015;58:174–81.CrossRefPubMed Bödeker B, et al. Influenza, tetanus, and pertussis vaccination coverage among adults in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015;58:174–81.CrossRefPubMed
10.
go back to reference Robert-Koch-Institut, Epidemiologisches Bulletin 01/17. 2017. Robert-Koch-Institut, Epidemiologisches Bulletin 01/17. 2017.
11.
go back to reference Robert-Koch-Institut, Epidemiologisches Bulletin Ausgabe 44/19. 2019. Robert-Koch-Institut, Epidemiologisches Bulletin Ausgabe 44/19. 2019.
13.
go back to reference Poethko-Müller C, Schmitz R. Vaccination coverage in German adults: results of the German health interview and examination survey for adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:845–57.CrossRefPubMed Poethko-Müller C, Schmitz R. Vaccination coverage in German adults: results of the German health interview and examination survey for adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:845–57.CrossRefPubMed
14.
go back to reference Valour F, et al. Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients. Vaccine. 2014;32(35):4558–64.CrossRefPubMed Valour F, et al. Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients. Vaccine. 2014;32(35):4558–64.CrossRefPubMed
15.
16.
go back to reference Martins S, et al. Vaccination coverage and immunity against hepatitis B among HIV-infected patients in South Brazil. Braz J Infect Dis. 2015;19:181–6.CrossRefPubMedPubMedCentral Martins S, et al. Vaccination coverage and immunity against hepatitis B among HIV-infected patients in South Brazil. Braz J Infect Dis. 2015;19:181–6.CrossRefPubMedPubMedCentral
18.
go back to reference Robert-Koch-Institut, Epidemiologisches Bulletin 46/19. 2019. Robert-Koch-Institut, Epidemiologisches Bulletin 46/19. 2019.
19.
go back to reference Rogers CJ, Bahr KO, Benjamin SM. Attitudes and barriers associated with seasonal influenza vaccination uptake among public health students; a cross-sectional study. BMC Public Health. 2018;18:1131.CrossRefPubMedPubMedCentral Rogers CJ, Bahr KO, Benjamin SM. Attitudes and barriers associated with seasonal influenza vaccination uptake among public health students; a cross-sectional study. BMC Public Health. 2018;18:1131.CrossRefPubMedPubMedCentral
20.
go back to reference Harrison N, et al. Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey. HIV Med. 2017;18:500–6.CrossRefPubMed Harrison N, et al. Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey. HIV Med. 2017;18:500–6.CrossRefPubMed
21.
go back to reference Tsachouridou O, et al. Factors associated with poor adherence to vaccination against hepatitis viruses, streptococcus pneumoniae and seasonal influenza in HIV-infected adults. Hum Vaccin Immunother. 2019;15:295–304.CrossRefPubMed Tsachouridou O, et al. Factors associated with poor adherence to vaccination against hepatitis viruses, streptococcus pneumoniae and seasonal influenza in HIV-infected adults. Hum Vaccin Immunother. 2019;15:295–304.CrossRefPubMed
22.
go back to reference Mereckiene J, et al. Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). Euro Surveill. 2014;19:20780.CrossRefPubMed Mereckiene J, et al. Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). Euro Surveill. 2014;19:20780.CrossRefPubMed
23.
go back to reference Robert-Koch-Institut, Epidemdiologisches Bulletin 34/2020. 2020. Robert-Koch-Institut, Epidemdiologisches Bulletin 34/2020. 2020.
24.
go back to reference Kratz MM, et al. Community-based outbreak of Neisseria meningitidis serogroup C infection in men who have sex with men, New York City, New York, USA, 2010–2013. Emerg Infect Dis. 2015;21:1379–86.CrossRefPubMedPubMedCentral Kratz MM, et al. Community-based outbreak of Neisseria meningitidis serogroup C infection in men who have sex with men, New York City, New York, USA, 2010–2013. Emerg Infect Dis. 2015;21:1379–86.CrossRefPubMedPubMedCentral
25.
go back to reference Hellenbrand W, et al. Risk of invasive meningococcal disease in men who have sex with men: lessons learned from an outbreak in Germany, 2012–2013. PLoS ONE. 2016;11: e0160126.CrossRefPubMedPubMedCentral Hellenbrand W, et al. Risk of invasive meningococcal disease in men who have sex with men: lessons learned from an outbreak in Germany, 2012–2013. PLoS ONE. 2016;11: e0160126.CrossRefPubMedPubMedCentral
26.
go back to reference Marcus U, et al. A cluster of invasive meningococcal disease in young men who have sex with men in Berlin, October 2012 to May 2013. Euro Surveill. 2013;18:20523.CrossRefPubMed Marcus U, et al. A cluster of invasive meningococcal disease in young men who have sex with men in Berlin, October 2012 to May 2013. Euro Surveill. 2013;18:20523.CrossRefPubMed
27.
go back to reference Kamiya H, et al. Meningococcal disease among men who have sex with men—United States, January 2012–June 2015. MMWR Morb Mortal Wkly Rep. 2015;64:1256–7.CrossRefPubMed Kamiya H, et al. Meningococcal disease among men who have sex with men—United States, January 2012–June 2015. MMWR Morb Mortal Wkly Rep. 2015;64:1256–7.CrossRefPubMed
Metadata
Title
Implementation of EACS vaccination recommendations among people living with HIV
Authors
Sven Breitschwerdt
Carolynne Schwarze-Zander
Ahmad Al Tayy
Julia Mutevelli
Jan-Christian Wasmuth
Jürgen K. Rockstroh
Christoph Boesecke
Publication date
06-05-2022
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2022
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-022-01827-6

Other articles of this Issue 6/2022

Infection 6/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.